{"id":325808,"date":"2026-10-26T10:08:25","date_gmt":"2026-10-26T04:38:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=325808"},"modified":"2026-10-26T10:08:25","modified_gmt":"2026-10-26T04:38:25","slug":"midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap Stocks Trading Near 52 Week High to Watch for Future Multibagger Potential: Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Coforge Rs 1,900.50. Federal Bank Rs 340.90. Fortis Healthcare Rs 712.90. Dr Lal PathLabs Rs 1,838.20. Market caps from Rs 31,675 crore to Rs 86,393 crore. Data as of 23 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs are the 4 picks in this stocks trading near 52 week high watchlist, with market caps between Rs 31,675 crore and Rs 86,393 crore. Coforge stands out for the fastest profit growth, 23.72% a year since FY22, while Federal Bank offers the biggest five-year price gain at 259.57%. PE ratios run from 15.47 to 57.98, so compare each one with its industry PE before investing. All figures are as of 23 October 2026.<\/p>\n<\/p><\/div>\n<p>Stocks trading near 52 week high to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs meet that test, with market caps from Rs 31,675 crore to Rs 86,393 crore and Coforge offering the fastest profit growth, 23.72% a year since FY22. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price within 10 per cent of its 52-week high, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price within 10 per cent of its 52-week high, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening stocks trading near 52 week high usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 23 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=stocks-trading-near-week-high\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#What_Are_Stocks_Trading_Near_52_Week_High_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Stocks Trading Near 52 Week High and Why Do They Attract Multibagger Interest?\">What Are Stocks Trading Near 52 Week High and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Stocks_Trading_Near_52_Week_High_at_a_Glance_Price_Market_Cap_PE_ROE_and_Price_to_Book\" title=\"Stocks Trading Near 52 Week High at a Glance: Price, Market Cap, PE, ROE and Price to Book\">Stocks Trading Near 52 Week High at a Glance: Price, Market Cap, PE, ROE and Price to Book<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Coforge_2372_Profit_CAGR_Since_FY22\" title=\"Coforge: 23.72% Profit CAGR Since FY22\">Coforge: 23.72% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Federal_Bank_2290_Profit_CAGR_Since_FY22\" title=\"Federal Bank: 22.90% Profit CAGR Since FY22\">Federal Bank: 22.90% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Fortis_Healthcare_Five-Year_Gain_of_24147\" title=\"Fortis Healthcare: Five-Year Gain of 241.47%\">Fortis Healthcare: Five-Year Gain of 241.47%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Dr_Lal_PathLabs_Return_on_Equity_of_2013\" title=\"Dr Lal PathLabs: Return on Equity of 20.13%\">Dr Lal PathLabs: Return on Equity of 20.13%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Stocks_Trading_Near_52_Week_High_Financial_Comparison_on_Growth_and_Margins\" title=\"Stocks Trading Near 52 Week High: Financial Comparison on Growth and Margins\">Stocks Trading Near 52 Week High: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Institutional_Holding_in_Coforge_Federal_Bank_Fortis_Healthcare_and_Dr_Lal_PathLabs\" title=\"Institutional Holding in Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs\">Institutional Holding in Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Stocks_Trading_Near_52_Week_High\" title=\"Risks to Weigh in Stocks Trading Near 52 Week High\">Risks to Weigh in Stocks Trading Near 52 Week High<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#How_to_Choose_Between_Stocks_Trading_Near_52_Week_High\" title=\"How to Choose Between Stocks Trading Near 52 Week High\">How to Choose Between Stocks Trading Near 52 Week High<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Stocks_Trading_Near_52_Week_High_to_Watch\" title=\"Frequently Asked Questions on Stocks Trading Near 52 Week High to Watch\">Frequently Asked Questions on Stocks Trading Near 52 Week High to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Which_are_the_best_stocks_trading_near_52_week_high_to_watch_for_multibagger_potential\" title=\"Which are the best stocks trading near 52 week high to watch for multibagger potential?\">Which are the best stocks trading near 52 week high to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Is_Dr_Lal_PathLabs_a_good_stock_for_long-term_investors\" title=\"Is Dr Lal PathLabs a good stock for long-term investors?\">Is Dr Lal PathLabs a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Can_Coforge_become_a_multibagger_from_here\" title=\"Can Coforge become a multibagger from here?\">Can Coforge become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Coforge_Federal_Bank_Fortis_Healthcare_and_Dr_Lal_PathLabs\" title=\"What is the market cap of Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs?\">What is the market cap of Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_stocks_trading_near_52_week_high\" title=\"What are the risks of investing in stocks trading near 52 week high?\">What are the risks of investing in stocks trading near 52 week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#Why_is_Coforge_trading_at_a_PE_of_4499\" title=\"Why is Coforge trading at a PE of 44.99?\">Why is Coforge trading at a PE of 44.99?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-trading-near-52-week-high-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Coforge_Federal_Bank_Fortis_Healthcare_and_Dr_Lal_PathLabs\" title=\"How much do institutions hold in Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs?\">How much do institutions hold in Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Stocks_Trading_Near_52_Week_High_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Stocks Trading Near 52 Week High and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Stocks trading near 52 week high are shares of mid sized companies trading close to their highest price of the past year, often a sign of strong demand. The four here cover IT services, private banking, hospitals and diagnostics.<\/p>\n<p>A stock near its yearly high with rising profit shows the market is rewarding real progress. For stocks trading near 52 week high, both FY26 and the latest quarter showed growth. A sensible way to study stocks trading near 52 week high is to look at profit growth, returns and valuation side by side. Below, each of stocks trading near 52 week high gets its own breakdown of growth, returns and valuation. Treat stocks trading near 52 week high as a research list, since share prices and rankings change with every earnings season.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_Trading_Near_52_Week_High_at_a_Glance_Price_Market_Cap_PE_ROE_and_Price_to_Book\"><\/span><strong>Stocks Trading Near 52 Week High at a Glance: Price, Market Cap, PE, ROE and Price to Book<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 23 October 2026. Federal Bank has the lowest PE of the group at 15.47, while Dr Lal PathLabs posts the highest return on equity at 20.13%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Price to Book<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/coforge\/coforge-ltd-share-price-today\">Coforge<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,900.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">86,393<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44.99<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.66<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3.28<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,008.10 to 2,021.20<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/federalbnk\/the-federal-bank-ltd-share-price-today\">Federal Bank<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">340.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">83,333<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.47<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.60%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2.02<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">211.52 to 371.70<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fortis\/fortis-healthcare-ltd-share-price-today\">Fortis Healthcare<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">712.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56,063<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.37<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.67<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">565.00 to 757.40<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr Lal PathLabs<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,838.20<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31,675<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">57.98<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.13%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.63<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,272.60 to 2,038.60<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Coforge_2372_Profit_CAGR_Since_FY22\"><\/span><strong>Coforge: 23.72% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Coforge is an IT services company serving clients in travel, banking, insurance and other industries. It reported FY26 revenue of Rs 16,475.90 crore, up 34.63% year on year, and net profit of Rs 1,674.50 crore, up 73.79%. Net profit has compounded at 23.72% a year since FY22, while revenue has grown 26.26% a year. Operating margin was 17.40% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 49.19% to Rs 5,554.50 crore and net profit grew 49.19% to Rs 531.70 crore. The share price has gained 73.24% over five years and 10.25% over the past year. The stock trades at a PE of 44.99 against an industry PE of 17.66, with a return on equity of 16.31%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Federal_Bank_2290_Profit_CAGR_Since_FY22\"><\/span><strong>Federal Bank: 22.90% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Federal Bank is a Kerala-based private sector bank with a strong NRI deposit base and a growing retail, small business and digital franchise. It reported FY26 total income of Rs 34,272.42 crore, up 7.00% year on year, and net profit of Rs 4,483.38 crore, up 6.71%. Net profit has compounded at 22.90% a year since FY22, while total income has grown 20.05% a year.<\/p>\n<p>The stock trades at a PE of 15.47 against an industry PE of 11.94, with a return on equity of 12.60%. In the September 2026 quarter, total income rose 19.01% to Rs 9,903.41 crore and net profit grew 53.42% to Rs 1,564.06 crore. The share price has gained 259.57% over five years and 57.58% over the past year. Domestic institutions raised their holding from 48.17% in June 2025 to 49.28% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_Five-Year_Gain_of_24147\"><\/span><strong>Fortis Healthcare: Five-Year Gain of 241.47%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Fortis Healthcare operates a chain of hospitals and diagnostic centres across India. It reported FY26 revenue of Rs 9,178.50 crore, up 16.93% year on year, and net profit of Rs 1,064.19 crore, up 31.48%. Net profit has compounded at 7.73% a year since FY22, while revenue has grown 12.43% a year. Operating margin was 22.41% in FY26. The debt-to-equity ratio is 0.35.<\/p>\n<p>In the June 2026 quarter, revenue rose 17.29% to Rs 2,559.50 crore and net profit grew 2.26% to Rs 272.80 crore. The share price has gained 241.47% over five years. Domestic institutions raised their holding from 29.79% in June 2025 to 32.23% in June 2026. The stock trades at a PE of 52.37 against an industry PE of 60.75, below the sector average.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_PathLabs_Return_on_Equity_of_2013\"><\/span><strong>Dr Lal PathLabs: Return on Equity of 20.13%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr Lal PathLabs is one of India&#8217;s leading diagnostic chains, running laboratories and collection centres across the country. It reported FY26 revenue of Rs 2,864.18 crore, up 12.11% year on year, and net profit of Rs 509.75 crore, up 3.56%. Net profit has compounded at 9.83% a year since FY22, while revenue has grown 7.56% a year. Operating margin was 30.90% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 57.98 against an industry PE of 60.75, below the sector average, with a return on equity of 20.13%. In the June 2026 quarter, revenue rose 18.87% to Rs 829.60 crore and net profit grew 27.24% to Rs 170.50 crore. The share price is up 19.11% over the past year. Domestic institutions raised their holding from 17.91% in June 2025 to 21.59% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_Trading_Near_52_Week_High_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Stocks Trading Near 52 Week High: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these stocks trading near 52 week high. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Coforge<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16,475.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,674.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.63%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.26%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.72%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Federal Bank<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34,272.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,483.38<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.00%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.05%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.90%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Fortis Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,178.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,064.19<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.93%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.43%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.73%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Dr Lal PathLabs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,864.18<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">509.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.11%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.83%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these stocks trading near 52 week high<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Coforge_Federal_Bank_Fortis_Healthcare_and_Dr_Lal_PathLabs\"><\/span><strong>Institutional Holding in Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these stocks trading near 52 week high alongside the promoter. The table uses the latest reported quarter for each. Federal Bank has the deepest institutional backing, with FII and DII together holding 76.99% as of June 2026. Domestic institutions increased their holding over the past year in Federal Bank (from 48.17% to 49.28%), Fortis Healthcare (from 29.79% to 32.23%) and Dr Lal PathLabs (from 17.91% to 21.59%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Coforge<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Nil<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">33.07%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Federal Bank<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Nil<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.71%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">49.28%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.01%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Fortis Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.17%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.20%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.23%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.40%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Dr Lal PathLabs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">53.19%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.59%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.86%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Stocks_Trading_Near_52_Week_High\"><\/span><strong>Risks to Weigh in Stocks Trading Near 52 Week High<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with stocks trading near 52 week high means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Coforge trades at a PE of 44.99 against an industry PE of 17.66, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Stocks_Trading_Near_52_Week_High\"><\/span><strong>How to Choose Between Stocks Trading Near 52 Week High<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from stocks trading near 52 week high comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (11.94 to 60.75) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among stocks trading near 52 week high, Coforge stands out for the fastest profit growth, 23.72% a year since FY22, Federal Bank for the biggest five-year price gain at 259.57%, Fortis Healthcare for 16.93% revenue growth in FY26 and Dr Lal PathLabs for the highest return on equity at 20.13%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks trading near 52 week high should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Stocks_Trading_Near_52_Week_High_to_Watch\"><\/span><strong>Frequently Asked Questions on Stocks Trading Near 52 Week High to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_stocks_trading_near_52_week_high_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best stocks trading near 52 week high to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs are the 4 names this list highlights, with market caps of Rs 86,393 crore, Rs 83,333 crore, Rs 56,063 crore and Rs 31,675 crore respectively. Coforge is notable for the fastest profit growth, 23.72% a year since FY22. Federal Bank stands out for the biggest five-year price gain at 259.57%. Fortis Healthcare offers 16.93% revenue growth in FY26. Dr Lal PathLabs brings the highest return on equity at 20.13%. These are watchlist names for stocks trading near 52 week high, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Dr_Lal_PathLabs_a_good_stock_for_long-term_investors\"><\/span><strong>Is Dr Lal PathLabs a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr Lal PathLabs has a return on equity of 20.13%, a PE of 57.98 against an industry PE of 60.75 and a market cap of Rs 31,675 crore. Net profit has compounded at 9.83% a year since FY22, and FY26 revenue rose 12.11% while June 2026 quarter net profit grew 27.24%. Long-term returns in stocks trading near 52 week high depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Coforge_become_a_multibagger_from_here\"><\/span><strong>Can Coforge become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Coforge has already gained 73.24% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks trading near 52 week high requires earnings to keep growing faster than the market for several years. Net profit has compounded at 23.72% a year since FY22, and FY26 revenue rose 34.63%. At a PE of 44.99 against an industry PE of 17.66, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Coforge_Federal_Bank_Fortis_Healthcare_and_Dr_Lal_PathLabs\"><\/span><strong>What is the market cap of Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 23 October 2026, Coforge has a market cap of Rs 86,393 crore, Federal Bank has a market cap of Rs 83,333 crore, Fortis Healthcare has a market cap of Rs 56,063 crore and Dr Lal PathLabs has a market cap of Rs 31,675 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks trading near 52 week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_stocks_trading_near_52_week_high\"><\/span><strong>What are the risks of investing in stocks trading near 52 week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Coforge trades at a PE of 44.99 against an industry PE of 17.66, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Coforge_trading_at_a_PE_of_4499\"><\/span><strong>Why is Coforge trading at a PE of 44.99?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Coforge&#8217;s PE of 44.99 compares with an industry PE of 17.66. The market is paying a premium for a return on equity of 16.31%, profit growth of 23.72% a year since FY22 and latest-quarter profit growth of 49.19%, which also means the stock is more sensitive if growth slows. Investors in stocks trading near 52 week high who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Coforge_Federal_Bank_Fortis_Healthcare_and_Dr_Lal_PathLabs\"><\/span><strong>How much do institutions hold in Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 66.93% of Coforge (24.31% and 42.62%), 76.99% of Federal Bank (27.71% and 49.28%), 57.43% of Fortis Healthcare (25.20% and 32.23%) and 38.95% of Dr Lal PathLabs (17.36% and 21.59%). Rising institutional holding is a useful signal in stocks trading near 52 week high, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best stocks trading near 52 week high to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs are the 4 names this list highlights, with market caps of Rs 86,393 crore, Rs 83,333 crore, Rs 56,063 crore and Rs 31,675 crore respectively. Coforge is notable for the fastest profit growth, 23.72% a year since FY22. Federal Bank stands out for the biggest five-year price gain at 259.57%. Fortis Healthcare offers 16.93% revenue growth in FY26. Dr Lal PathLabs brings the highest return on equity at 20.13%. These are watchlist names for stocks trading near 52 week high, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Dr Lal PathLabs a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr Lal PathLabs has a return on equity of 20.13%, a PE of 57.98 against an industry PE of 60.75 and a market cap of Rs 31,675 crore. Net profit has compounded at 9.83% a year since FY22, and FY26 revenue rose 12.11% while June 2026 quarter net profit grew 27.24%. Long-term returns in stocks trading near 52 week high depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Coforge become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Coforge has already gained 73.24% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks trading near 52 week high requires earnings to keep growing faster than the market for several years. Net profit has compounded at 23.72% a year since FY22, and FY26 revenue rose 34.63%. At a PE of 44.99 against an industry PE of 17.66, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 23 October 2026, Coforge has a market cap of Rs 86,393 crore, Federal Bank has a market cap of Rs 83,333 crore, Fortis Healthcare has a market cap of Rs 56,063 crore and Dr Lal PathLabs has a market cap of Rs 31,675 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks trading near 52 week high.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in stocks trading near 52 week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Coforge trades at a PE of 44.99 against an industry PE of 17.66, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Coforge trading at a PE of 44.99?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Coforge's PE of 44.99 compares with an industry PE of 17.66. The market is paying a premium for a return on equity of 16.31%, profit growth of 23.72% a year since FY22 and latest-quarter profit growth of 49.19%, which also means the stock is more sensitive if growth slows. Investors in stocks trading near 52 week high who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 66.93% of Coforge (24.31% and 42.62%), 76.99% of Federal Bank (27.71% and 49.28%), 57.43% of Fortis Healthcare (25.20% and 32.23%) and 38.95% of Dr Lal PathLabs (17.36% and 21.59%). Rising institutional holding is a useful signal in stocks trading near 52 week high, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 midcap stocks trading near 52 week high compared on market cap, PE, ROE, growth and institutional holding: Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs.<\/p>\n","protected":false},"author":33,"featured_media":325807,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[15583,15584],"class_list":["post-325808","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-stocks-trading-near-52-week-high","tag-stocks-trading-near-52-week-high-sector"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["325807"],"rank_math_title":["Stocks Trading Near 52 Week High 2026: Coforge, Federal Bank"],"rank_math_description":["Stocks trading near 52 week high to watch for multibagger potential: Coforge, Federal Bank, Fortis Healthcare and Dr Lal PathLabs. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["stocks trading near 52 week high"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-midcap-stocks-trading-near-52-week-high-to-watch-for-future-multibagger.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/325808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=325808"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/325808\/revisions"}],"predecessor-version":[{"id":325809,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/325808\/revisions\/325809"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/325807"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=325808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=325808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=325808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}